Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial
- Posted on August 19, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
